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SUPPLEMENTARY NOTES
ABSTRACT
Inflammatory bowel disease is associated with the relative increase in the population of Proteobacteria compared to other bacterial phyla, which in turn might be linked to cancer predisposition. Using a Drosophila melanogaster model of intestinal infection we have investigated various human intestinal bacteria, including Proteobacteria and screened for the inflammatory responses they elicit individually or in binary combinations. We find that some highly inflammatory bacterial strains loose their inflammatory effect when in combination with other highly inflammatory strains. Thus specific bacterial compositions rather than mere presence or absence of bacterial species dictates the degree of bacterially-driven intestinal inflammation. 
SUBJECT TERMS
INTRODUCTION
Until now it remains unknown if a relative increase in the population of Proteobacteria in comparison with other abundant bacterial phyla is a cause or a result of inflammatory bowel disease (IBD). Our study aimed to assess systematically for the first time the differences in inflammatory potential of a broad array of human intestinal bacteria in order to identify specific bacterial species and combinations thereof for their ability to promote intestinal inflammation. Using a Drosophila melanogaster model of intestinal infection we have investigated various human intestinal bacteria, predominantly Proteobacteria which can easily colonize the Drosophila intestine. We assessed the inflammatory responses elicited by individual bacterial strains. To challenge the assumption that highly inflammatory species will also be virulent in the presence of other inflammatory bacteria we prioritized assessments of combinations of highly inflammatory stains in an attempt to identify competitive bacterial interactions. We find bacterial species that while high inflammatory when mono--associated with the host, they loose their damaging ability when in combination with other damaging strains. Thus specific bacterial combinations rather than the presence of particular species per se result in a low intestinal inflammation status in our experimental model.
BODY
Intestinal microbiota composition is critical in intestinal inflammation and their perturbations are linked to Inflammatory Bowel Disease (IBD). Other than Helicobacter pylori in gastric ulcer and cancer, no other bacterial species has been accepted as a causative agent of chronic gastrointestinal inflammation and cancer (Zabaleta, 2012 According to our Statement of Work (SOW) (please refer to the end of this section for the pertinent Task 1 and Task 2, as they were originally proposed) we aimed to assess the effect of human intestinal Proteobacteria and other intestinal bacterial species on epithelial inflammation. The human intestine contains mainly anaerobic bacterial species belonging to the phyla Firmicures and Bacteroidetes and to lesser extent aerobic Proteobacteria species. Nevertheless, the latter are more likely to survive in the aerobic environment of the Drosophila intestine. In addition, Proteobacteria are hypothesized to be instigators in IBD. Thus instead of selecting an equal number of 32 Proteobacteria vs 32 Firmicutes and Bacteroides bacterial strains, as we had proposed in Task 1, we assessed 29 of the former and 6 of the latter, all of which are able to colonize the Drosophila intestine. The most important part of Task 1 was to assess all selected human strains for their inflammatory potential. We measured the average and standard deviation of mitgut mitosis from ~20 midguts per bacterial strain (Figure 1, unpublished) . While intestinal bacteria that cause disease in humans can occasionally cause disease in other organisms, the extent to which a Drosophila host can predict the pathogenic potential of human intestinal bacteria is not known. Accordingly, we found a good correlation between human intestinal bacteria that induce significant regeneration, i.e. mitosis, in the Drosophila intestine and their known potential to be pathogenic in humans. Out of our diverse panel of 35 culturable human intestinal bacterial strains, 17 can significantly increase intestinal cell mitosis, a quantitative marker of intestinal inflammation ( Figure   Figure' depicts' 17' human' intes3nal' bacteria' (red' frame)' found' to' be' highly' inflammatory' and' 7' low' inflammatory' strains' (blue' frame)' in' our' model' of' intes3nal' inflamma3on' in' Drosophila.+ Mito3c' index' in' the' Drosophila' midgut' is' indica3ve'of'the'poten3al'of'these'microbes'to'induce'intes3nal'inflamma3on.' 
17# 1). Strikingly, all 17 strains have been previously associated with opportunistic and other infections in
humans, yet none of the 7 strains considered non--pathogenic in humans induced significant intestinal mitosis in flies (Figure 1) . Thus there is a high correlation between potential pathogenicity in humans and enterocyte damage and regeneration/mitosis in the Drosophila intestine. With the 35 strains in hand we worked on the most laborious and time consuming part of SOW, the assessment of the inflammatory potential of the strains introduced in binary combinations in the Drosophila intestine. In our original Task 2 we proposed to assess the selected Proteobacteria in 1:1 combinations with the selected Firmicutes/Bacteroidetes species. Nevertheless, our strain selection finally contained only a few Firmicutes/Bacteroidetes species, such as Lactobacillus and Bifidobacteria species (Figure 1) , most of which are considered to be beneficial to humans. In addition, we had to amend our protocol so as to increase the number of midguts we assess from 5 to ~12 per condition, a necessary change to make our results more reliable. Finally, we found it necessary to reproduce our findings in order to validate our results within the time frame of this award. Thus, we prioritized the combinatorial assessments proposed in Task 2, so as to combine 7 strains exhibiting the highest inflammation in mono--associated Drosophila with 20 strains exhibiting extreme inflammation (10 highest plus 10 lowest, according to the ranking shown in Figure 1) . We found that 48 strain combinations reduce the inflammatory potential of the top 7 inflammatory strains ( Table 1, unpublished) . Of those we verified 13 combinations i.e we observed qualitatively similar results upon repetition of the experiments ( Table 1) . For example, the highly inflammatory species Pseudomonas aeruginosa loose its inflammatory potential when in combination with the equally inflammatory species Escherichia coli, Vibrio colerae and Bacteroides fragilis. Similarly, the highly inflammatory species Enterococcus faecalis loose its inflammatory potential when in combination with the equally inflammatory species Vibrio colerae and Bacteroides fragilis. These findings are of great importance because they suggest that bacterial combinations can exert mutual antagonistic effects on intestinal inflammation. The information that even inflammatory bacterial strains may reduce the inflammatory potential of other bacteria could be exploited by clinicians in the prediction or treatment of intestinal inflammation. Pertinent adjustments in the microbiota of patients with intestinal inflammation may help to improve treatments against Inflammatory Bowel Disease (IBD), but also to reduce the risk of inflammation--driven tumorigenesis (Tanaka, 2012) . Originally proposed SOW Tasks: Task 1. Select 32 Proteobacteria and 32 Firmicutes/Bacteroidetes species that are can be transmitted to the Drosophila intestine upon feeding and assess if they induce intestinal inflammation (months 0--2): 1a. Collect 40 Proteobactia and 60 Firmicutes/Bacteroidetes species that are published to be common in the human intestine and have been cultured before (months 0--1). 1b. Out of these 100 species we will select 32 Proteobacteria and 32 Firmicutes/Bacteroidetes species that are can be transmitted to the Drosophila intestine upon feeding (months 1--2) . 1--2) . Task 2. Assess the selected Proteobacteria in 1:1 combinations with the selected Firmicutes/Bacteroidetes species (32x32=1024 combinations) for their ability to induce intestinal inflammation in Drosophila (months 3--12): 2a. Feed Drosophila with 1024 combinations of bacteria for 5 days, dissect out, fix and mount in a microscope slide 5 of their intestines (months 3--12) . 2b. Measure the average number of progenitor cells per bacterial stain combination and categorize accordingly (months 3--12) .
KEY RESEARCH ACCOMPLISHMENTS
• We selected a diverse panel of 35 culturable strains of human intestinal bacterial species, able to colonize the Drosophila intestine and assessed their inflammatory potential (Figure 1 ).
• Figure 1 data analysis shows that there is a high correlation between intestinal mitosis in the Drosophila midgut and the know pathogenicity potential in humans of the intestinal bacterial strains assessed.
• We assessed binary combinations of highly inflammatory strains and other strains (as shown in Table  1 ) to find that highly inflammatory species, such as Pseudomonas aeruginosa and Enterococcus faecalis loose their inflammatory potential when in combination with the equally inflammatory species Vibrio colerae and Bacteroides fragilis.
• Table  1 data analysis shows that bacterial combinations can exert mutual antagonistic effects on each other to diminish their impact on intestinal inflammation. REPORTABLE OUTCOMES Manuscripts stemming from this work will be accomplished in the future due to the short duration (1 year) and nature (screening) of this study. Nevertheless, below we list all the significant outcomes of our work: 
